Rowex Ltd. have announced the launch of Rhinex Relief 50 micrograms/actuation nasal spray.
Each actuation of the pump delivers a metered dose of 50 micrograms of mometasone furoate (as mometasone furoate monohydrate).
The total weight of one actuation is 100 mg.
Therapeutic Indications:
Rhinex Relief is indicated for use in adults to treat the symptoms of seasonal allergic rhinitis, after a seasonal allergic rhinitis has been diagnosed by a physician.
| BRAND NAME | STRENGTH | PACK SIZE | LEGAL CATEGORY | PA NUMBER | BARCODE | TRADE PRICE |
| Rhinex Relief | 50 micrograms/ actuation nasal spray, suspension | Packs of 1 x 60 dose | OTC | PA0711/279/001 | 5390387990014 | € 5.50 |
For further information or to order contact the Rowex® Telesales Team: Irene, Jeanne Marie or Rita on 1800 304 400
Product not subject to medical prescription. Further information and SPC are available from the Marketing Authorisation Holder: Rowex Ltd., Bantry, Co. Cork, P75 V009 Freephone: 1800 304 400 Fax: 027 50417
E-mail: rowex@rowa-pharma.ie
